104 related articles for article (PubMed ID: 7065969)
21. Cytokine regulation of C3 and C5 production by human corneal fibroblasts.
Rothman B; Despins A; Webb S; Taylor D; Sundarraj N; O'Rourke J; Kreutzer D
Exp Eye Res; 1991 Sep; 53(3):353-61. PubMed ID: 1718772
[TBL] [Abstract][Full Text] [Related]
22. Evidence for restriction of the ability of complement to lyse homologous erythrocytes.
Houle JJ; Hoffmann EM
J Immunol; 1984 Sep; 133(3):1444-52. PubMed ID: 6430999
[TBL] [Abstract][Full Text] [Related]
23. Quantitative determination of complement components produced by purified hepatocytes.
Ramadori G; Rasokat H; Burger R; Meyer Zum Büschenfelde KH; Bitter-Suermann D
Clin Exp Immunol; 1984 Jan; 55(1):189-96. PubMed ID: 6692595
[TBL] [Abstract][Full Text] [Related]
24. Synthesis of the first component of complement by primary cultures of human tumors of the colon and urogenital tract and comparable normal tissue.
Bing DH; Spurlock SE; Bern MM
Clin Immunol Immunopathol; 1975 Sep; 4(3):341-51. PubMed ID: 1238213
[No Abstract] [Full Text] [Related]
25. Modulation of complement gene expression by glucocorticoids.
Lappin DF; Whaley K
Biochem J; 1991 Nov; 280 ( Pt 1)(Pt 1):117-23. PubMed ID: 1741740
[TBL] [Abstract][Full Text] [Related]
26. Complement biosynthesis by the human hepatoma-derived cell line HepG2.
Morris KM; Aden DP; Knowles BB; Colten HR
J Clin Invest; 1982 Oct; 70(4):906-13. PubMed ID: 6288774
[TBL] [Abstract][Full Text] [Related]
27. The effect of systemic decomplementation with cobra venom factor on corneal complement levels in guinea pigs.
Pleyer U; Mondino BJ; Sumner HL
Invest Ophthalmol Vis Sci; 1992 Jun; 33(7):2212-5. PubMed ID: 1607231
[TBL] [Abstract][Full Text] [Related]
28. Silica induced suppression of the production of third and fifth components of the complement system by human lung cells in vitro.
Rothman BL; Contrino J; Merrow M; Despins A; Kennedy T; Kreutzer DL
Immunopharmacol Immunotoxicol; 1994 Nov; 16(4):525-51. PubMed ID: 7876460
[TBL] [Abstract][Full Text] [Related]
29. Hemolytic complement and its components in Syrian hamsters: a study of five strains uninfected and infected with Brugia pahangi.
Barta O; Oyekan PP; Malone JB; Klei TR
Adv Exp Med Biol; 1981; 134():103-10. PubMed ID: 7223531
[TBL] [Abstract][Full Text] [Related]
30. Regulation of the synthesis of C1 subcomponents and C1-inhibitor.
Gulati P; Lemercier C; Guc D; Lappin D; Whaley K
Behring Inst Mitt; 1993 Dec; (93):196-203. PubMed ID: 8172568
[TBL] [Abstract][Full Text] [Related]
31. A novel assay for serum complement activity: C42 generation assay.
Kobayashi E; Kitano E; Kitamura H
Int Arch Allergy Immunol; 1999 Sep; 120(1):71-7. PubMed ID: 10529591
[TBL] [Abstract][Full Text] [Related]
32. In vitro synthesis of some complement components (C1q, C3 and C4) by lymphoid tissues and circulating leucocytes in man.
Lai A Fat RF; van Furth R
Immunology; 1975 Feb; 28(2):359-68. PubMed ID: 804438
[TBL] [Abstract][Full Text] [Related]
33. Biosynthesis of the third and fifth complement components by isolated human lung cells.
Rothman BL; Merrow M; Bamba M; Kennedy T; Kreutzer DL
Am Rev Respir Dis; 1989 Jan; 139(1):212-20. PubMed ID: 2912341
[TBL] [Abstract][Full Text] [Related]
34. Mode of interaction of different polyanions with the first (C1,C1) the second (C2) and the fourth (C4) component of complement. IV. Activation of C1 in serum by polyanions.
Loos M; Bitter-Suermann D
Immunology; 1976 Dec; 31(6):931-4. PubMed ID: 186401
[TBL] [Abstract][Full Text] [Related]
35. Nerve growth factor: activation of the classical complement pathway by specific substitution for component C1-.
Boyle MD; Young M
Proc Natl Acad Sci U S A; 1982 Apr; 79(8):2519-22. PubMed ID: 6953410
[TBL] [Abstract][Full Text] [Related]
36. Alternate and classical pathway components of complement in the normal cornea.
Mondino BJ; Ratajczak HV; Goldberg DB; Schanzlin DJ; Brown SI
Arch Ophthalmol; 1980 Feb; 98(2):346-9. PubMed ID: 6766301
[TBL] [Abstract][Full Text] [Related]
37. Expression and characterization of the C345C/NTR domains of complement components C3 and C5.
Thai CT; Ogata RT
J Immunol; 2003 Dec; 171(12):6565-73. PubMed ID: 14662858
[TBL] [Abstract][Full Text] [Related]
38. Leukocyte-derived complement inhibitor. IV. The functional properties of C1 bound to erythrocytes pretreated with leukocyte culture supernatant.
Bernard A; Walter W; Teshima H; Boumsell L; Good RA; Day NK
J Immunol; 1976 Oct; 117(4):1117-26. PubMed ID: 977945
[TBL] [Abstract][Full Text] [Related]
39. Selective cytotoxicity of monoclonal antibodies against fibroblasts: application in growth of human corneal epithelial cells in culture.
SundarRaj N; Sundar-Raj CV; Martin J
Curr Eye Res; 1984 Apr; 3(4):637-44. PubMed ID: 6370607
[TBL] [Abstract][Full Text] [Related]
40. Control of C1 activation by nascent C3b and C4b: a mechanism of feedback inhibition.
Ziccardi RJ
J Immunol; 1986 May; 136(9):3378-83. PubMed ID: 3485688
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
